4-碘-3-甲基苯甲酸乙酯 | 103204-07-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-碘-3-甲基苯甲酸乙酯
• 英文名称: 4-iodo-3-methyl-benzoic acid ethyl ester
• 英文别名: 4-Jod-3-methyl-benzoesaeure-aethylester；Ethyl 4-iodo-3-methylbenzoate
• CAS: 103204-07-5
• 化学式: C₁₀H₁₁IO₂
• mdl: MFCD12923263
• 分子量: 290.101
• InChiKey: POCCTDZBWSWSQQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-碘-3-甲基苯甲酸乙酯 在 chromium(VI) oxide 、 甲酸 、 硫酸 、 乙酸酐 、 溶剂黄146 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 33.0h， 生成 3-(5-(ethoxycarbonyl)-2-iodophenyl)propanoic acid
  参考文献：
  名称：

  Palladium-Catalyzed, Norbornene-Mediated, ortho-Amination ipso-Amidation: Sequential C–N Bond Formation

  摘要：

  A palladium-catalyzed, norbornene-mediated ortho- and ipso-C-N bond-forming Catellani reaction is reported. This reaction proceeds through a sequential intermolecular amination followed by intramolecular cyclization of a tethered amide. The products, ortho-aminated dihydroquinolinones, were generated in moderate to good yields and, are present in bioactive, molecules. This work highlights the challenge Of competing intra-vs intermolecular palladium-catalyzed processes.

  DOI：

  10.1021/acs.orglett.7b03577
• 作为产物：
  描述：

  乙醇 、 1-(2-异丙基苯基)-2-硫脲 在 硫酸 作用下， 反应 12.0h， 生成 4-碘-3-甲基苯甲酸乙酯
  参考文献：
  名称：

  Palladium-Catalyzed, Norbornene-Mediated, ortho-Amination ipso-Amidation: Sequential C–N Bond Formation

  摘要：

  A palladium-catalyzed, norbornene-mediated ortho- and ipso-C-N bond-forming Catellani reaction is reported. This reaction proceeds through a sequential intermolecular amination followed by intramolecular cyclization of a tethered amide. The products, ortho-aminated dihydroquinolinones, were generated in moderate to good yields and, are present in bioactive, molecules. This work highlights the challenge Of competing intra-vs intermolecular palladium-catalyzed processes.

  DOI：

  10.1021/acs.orglett.7b03577

文献信息

• [EN] MORPHOLINYL CONTAINING BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION<br/>[FR] BENZIMIDAZOLES CONTENANT DU MORPHOLINYLE EN TANT QU'INHIBITEURS DE LA REPLICATION DU VIRUS RESPIRATOIRE SYNCYTIAL
  申请人：TIBOTEC PHARM LTD

  公开号：WO2005058871A1

  公开（公告）日：2005-06-30

  The present invention concerns morpholinyl containing benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formula (I), a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein G is a direct bond or optionally substituted C1-10alkanediyl; Rl is Ar1 or a monocyclic or bicyclic heterocycle Q is R7, pyrrolidinyl substituted with R7, piperidinyl substituted with R7 or homopiperidinyl substituted with R7; one of R2a and R3a is selected from halo, optionally mono- or polysubstituted Cl-6alkyl, optionally mono- or polysubstituted C2-6alkenyl, nitro, hydroxy, Ar2, N(R4aR4), N(R4aR4)sulfonyl, N(R4aR4b)carbonyl, C1-6alkyloxy, Ar2oxy, Ar2Cl-6alkyloxy, carboxyl, Cl-6alkyloxycarbonyl, or -C(=Z)Ar2; and the other one of R2a and R3a is hydrogen; in case R2a is different from hydrogen then R2b is hydrogen, C1-6alkyl or halogen and R3b is hydrogen; in case R3a is different from hydrogen then R3b is hydrogen, C1-6alkyl or halogen and R2b is hydrogen. It further concerns the preparation thereof and compositions comprising these compounds, as well as the use thereof as a medicine.

  本发明涉及含有对呼吸道合胞病毒复制具有抑制活性的吗啉基苯并咪唑的化合物，其具有式（I），一种前药、N-氧化物、加合盐、季铵盐、金属配合物或其立体化异构体，其中G是直键或可选择地取代的C1-10烷二基；R1是Ar1或单环或双环杂环；Q是R7，R7取代的吡咯烷基、R7取代的哌啶基或R7取代的同构异哌啶基；R2a和R3a中的一个选自卤素、可选择单取代或多取代的Cl-6烷基、可选择单取代或多取代的C2-6烯基、硝基、羟基、Ar2、N(R4aR4)、N(R4aR4)磺酰基、N(R4aR4b)羰基、C1-6烷氧基、Ar2氧基、Ar2Cl-6烷氧基、羧基、Cl-6烷氧羰基或-C(=Z)Ar2；R2a和R3a中的另一个是氢；如果R2a与氢不同，则R2b是氢、C1-6烷基或卤素，R3b是氢；如果R3a与氢不同，则R3b是氢、C1-6烷基或卤素，R2b是氢。还涉及其制备以及包含这些化合物的组合物，以及其作为药物的用途。
• Protodemetalation of (Bipyridyl)Ni(II)–Aryl Complexes Shows Evidence for Five-, Six-, and Seven-Membered Cyclic Pathways
  作者：Paige E. Piszel、Brandon J. Orzolek、Alyssa K. Olszewski、Madeline E. Rotella、Amanda M. Spiewak、Marisa C. Kozlowski、Daniel J. Weix

  DOI：10.1021/jacs.3c00618

  日期：——

  protodemetalation (PDM) of a suite of arylnickel(II) complexes with various acids that provide evidence for a concerted, cyclic transition state for the PDM of C–Ni bonds and demonstrate that five-, six-, and seven-membered transition states are particularly favorable. Our data show that while the rate of protodemetalation of arylnickel(II) complexes scales with acidity for many acids, several are faster

  C-M 键的质子化及其微观反向，即 C-H 键的金属化，是各种金属催化过程中的基本步骤。因此，对 C-M 键质子化的研究可以阐明 C-H 激活。我们在这里介绍了一组芳基镍 （II） 配合物与各种酸的原生脱金属速率 （PDM） 的研究，这些研究为 C-Ni 键的 PDM 的协同循环过渡态提供了证据，并证明五元、六元和七元过渡态特别有利。我们的数据表明，虽然芳基镍 （II） 络合物的原生脱金属速率随许多酸的酸度而变化，但有些酸的比 pKa 预测的要快。例如，虽然乙酸和乙酰氢肟酸的酸性比 HCl 低得多，但它们对芳基镍 （II） 络合物的原型脱金属速度都比 HCl 快得多。我们的数据还表明，在乙酰异羟肟酸的情况下，七元环状过渡态 （CH3C（O）NHOH） 比六元过渡态 （CH3C（O）NHOH） 更有利。同样，五元过渡态，例如吡唑，也非常有利。过渡态极化的比较（来自密度泛函理论）将这些新的镍过
• Estrogenic Biphenyls. V. Steric Effect in 2,2′-Dialkyl-4-methoxybiphenyl-4′-carboxylic Acids
  作者：Takeo Sato

  DOI：10.1246/bcsj.32.1130

  日期：1959.10
• BENZAMIDE OR BENZAMINE COMPOUNDS USEFUL AS ANTICANCER AGENTS FOR THE TREATMENT OF HUMAN CANCERS
  申请人：THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

  公开号：US20170114062A1

  公开（公告）日：2017-04-27

  The described invention provides small molecule anti-cancer compounds for treating tumors that respond to cholesterol biosynthesis inhibition. The compounds selectively inhibit the cholesterol biosynthetic pathway in tumor-derived cancer cells, but do not affect normally dividing cells.
• Palladium-Catalyzed, Norbornene-Mediated, <i>ortho</i>-Amination <i>ipso</i>-Amidation: Sequential C–N Bond Formation
  作者：Andrew Whyte、Maxwell E. Olson、Mark Lautens

  DOI：10.1021/acs.orglett.7b03577

  日期：2018.1.19

  A palladium-catalyzed, norbornene-mediated ortho- and ipso-C-N bond-forming Catellani reaction is reported. This reaction proceeds through a sequential intermolecular amination followed by intramolecular cyclization of a tethered amide. The products, ortho-aminated dihydroquinolinones, were generated in moderate to good yields and, are present in bioactive, molecules. This work highlights the challenge Of competing intra-vs intermolecular palladium-catalyzed processes.